Our previous study confirmed that the expression of hyaluronan synthase 3 (HAS3) and CD44 is elevated in gliomas; on the one hand, increased HAS3 expression can promote HA biosynthesis, and on the other hand, overexpressed CD44 can combine with HA to accelerate glioma progression [10]. The gene discussed is CD44; the disease is central nervous system cancer.